COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1271: Articles 12701-12710  | Next

Reduced magnitude and durability of humoral immune responses by COVID-19 mRNA vaccines among older adults
Brockman, M. A., Mwimanzi, F. M., Lapointe, H. R., Sang, Y., Agafitei, O., Cheung, P., Ennis, S., Ng, K., Basra, S., Lim, L. Y., Yaseen, F., Young, L., Umviligihozo, G., Omondi, F. H., Kalikawe, R., Burns, L., Brumme, C. J., Leung, V., Montaner, J., Holmes, D., DeMarco, M., Simons, J., Pantophlet, R., Niikura, M., Romney, M. G., Brumme, Z. L.
10.1101/2021.09.06.21263149 — Posted: 2021-09-12
Exposures to different SARS-CoV-2 spike variants elicit neutralizing antibody responses with differential specificity towards established and emerging strains
Laurie, M. T., Liu, J., Sunshine, S., Peng, J., Black, D., Mitchell, A. M., Mann, S. A., Pilarowski, G., Zorn, K. C., Rubio, L., Bravo, S., Marquez, C., Petersen, M., Havlir, D., DeRisi, J.
10.1101/2021.09.08.21263095 — Posted: 2021-09-12
Analysis of SARS-CoV-2 variants from 24,181 patients exemplifies the role of globalisation and zoonosis in pandemics
Colson, P., Fournier, P.-E., Chaudet, H., Delerce, J., GIRAUD-GATINEAU, A., HOUHAMDI, L., ANDRIEU, C., BRECHARD, L., BEDOTTO, M., PRUDENT, E., GAZIN, C., BEYE, M., BUREL, E., DUDOUET, P., TISSOT-DUPONT, H., GAUTRET, P., LAGIER, J.-C., MILLION, M., BROUQUI, P., Parola, P., Drancourt, M., LA SCOLA, B., LEVASSEUR, A., Raoult, D.
10.1101/2021.09.10.21262922 — Posted: 2021-09-12
Effectiveness of the Single-Dose Ad26.COV2.S COVID Vaccine
Polinski, J. M., Weckstein, A. R., Batech, M., Kabelac, C., Kamath, T., Harvey, R., Jain, S., Rassen, J. A., Khan, N., Schneeweiss, S.
10.1101/2021.09.10.21263385 — Posted: 2021-09-12
Comprehensive Evaluation of COVID-19 Patient Short- and Long-term Outcomes: Disparities in Healthcare Utilization and Post-Hospitalization Outcomes
Salerno, S., Sun, Y., Morris, E. L., He, X., Li, Y., Pan, Z. P., Han, P., Kang, J., Sjoding, M. W., Li, Y.
10.1101/2021.09.07.21263213 — Posted: 2021-09-12
Elevated plasma levels of CXCL16 in severe COVID-19 patients
SMIESZEK, S. P., Polymeropoulos, V. M., Polymeropulos, C. M., Przychodzen, B. P., Birznieks, G., Polymeropoulos, M. M.
10.1101/2021.09.07.21263222 — Posted: 2021-09-12
Low dose prime and delayed boost can improve COVID-19 vaccine efficacies by increasing B cell selection stringency in germinal centres
Garg, A. K., Mittal, S., Padmanabhan, P., Desikan, R., Dixit, N. M.
10.1101/2021.09.08.21263248 — Posted: 2021-09-12
COVID-19 Outcomes in Patients with Cancer: Findings from the University of California Health System Database
Kwon, D. H., Cadena Pico, J. E., Nguyen, S., Chan, K. H. R., Soper, B., Gryshuk, A., Ray, P. H., Huang, F. W.
10.1101/2021.09.07.21263244 — Posted: 2021-09-12
University of Texas at Arlington (UTA) in-house COVID-19 testing program
Rudwick, R., Haseltine, F. P., Smith, A. G., Cox, N., Middleton, A., Guo, Z., Gunby, T.
10.1101/2021.09.08.21263264 — Posted: 2021-09-12
Serial evaluation of anti-SARS-CoV-2 IgG antibody and breakthrough infections in BNT162b2 Vaccinated migrant workers from Bangladesh
Hoque, A., Rahman, M. M., Das, A.
10.1101/2021.09.07.21263221 — Posted: 2021-09-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).